Inventor · disambiguated record
Xiaolin He
Also filed as: HE XIAOLIN
5 granted patents·6 pending applications·4 citations·filing 2018–2025
68Inventor score
Files withRISEN SUZHOU PHARMA TECH CO LTD11
Top patents by PatentIndex Score
11 records- 0192US11970490B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Apr 30, 2024·4 cites·24 claims
- 0284US2025353870A1Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2025·Application pending·0 cites
- 0379US12312378B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 0468US12365675B2Stable heavy isotopes in amide functional groups and uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2021·Granted Jul 22, 2025·0 cites·20 claims
- 0562US11591358B2Glucosamine derivatives and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Feb 28, 2023·0 cites·15 claims
- 0662US2024246963A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0761US2024239813A1Kras inhibitors and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0859US2024116952A1Kras inhibitor and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 0959US2023321253A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1058US2024059712A1Bifunctional compounds and pharmaceutical uses thereofRISEN SUZHOU PHARMA TECH CO LTD·Filed 2023·Application pending·0 cites
- 1143US11718636B2Glucosamine derivatives for the prevention or treatment of joint disordersRISEN SUZHOU PHARMA TECH CO LTD·Filed 2018·Granted Aug 8, 2023·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Xiaolin He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →